DoP may exempt 11 more drugs from public procurement rules that restricts global tender: Gireesh Babu, New Delhi Tuesday, January 13, 2026, 08:00 Hrs [IST] The Department of Pharm ...
SOUTH SAN FRANCISCO, Calif., January 12, 2026--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ ...
Dealbreaker on MSN
Aktis has first biotech IPO of 2026, raising $318M to expand the reach of radiopharmaceuticals
Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted ...
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback